SuperPC

SuperPC applies the supervised principal component approach to integrate gene expression and clinical outcomes for cancer subtype identification and prediction of censored survival and continuous regression outcomes from high-dimensional microarray datasets.

Key Features:

• Censored Survival Outcome Prediction: Predicts censored survival outcomes using models trained on integrated gene expression and survival-time data.
• Regression Outcome Analysis: Performs regression analysis for continuous clinical outcomes using gene expression predictors.
• Supervised Principal Component Method: Implements the supervised principal component technique to select features and reduce dimensionality in supervised prediction tasks.
• High-Dimensional Data Handling: Handles p >> n scenarios typical of microarray studies by combining feature selection with dimension reduction.
• Data Integration: Integrates gene expression profiles with clinical data such as survival times to inform model construction.
• Subtype Identification: Identifies distinct cancer subtypes from integrated molecular and clinical data without requiring predefined subtype labels.
• Predictive Modeling for Future Patients: Develops models that can be applied to predict survival or continuous outcomes for new patients based on expression profiles.

Scientific Applications:

• Cancer Subtype Discovery: Uncovers novel tumor subtypes by combining gene expression and clinical outcome data to assess tumor heterogeneity.
• Prognostic Modeling: Builds prognostic models to predict patient survival and continuous clinical outcomes from gene expression datasets.
• Microarray and High-Dimensional Expression Analysis: Applied to microarray and other high-dimensional gene expression datasets where features far exceed samples.

Methodology:

Integrates gene expression profiles with clinical outcomes (e.g., survival times) and applies the supervised principal component approach for feature selection and dimension reduction to identify subtypes and build predictive models for censored survival and continuous regression outcomes.